Pentixapharm Holding AG (ETR:PTP) | WebDisclosure

Basculer en Français

9474	Companies
185433	Keywords
117775	Articles
99293	Press releases

Headlines Articles Press releases Pentixapharm Holding AG

Home
Companies
Pentixapharm Holding AG

BRIEF

published on 12/03/2025 at 08:05, 2 days 2 hours ago

Pentixapharm se prépare à l'étude de phase 3 PANDA sur le diagnostic de l'hypertension

Hypertension Étude De Phase 3 Radiodiagnostic Commentaires De La FDA Ciblage De CXCR4
BRIEF

published on 12/03/2025 at 08:05, 2 days 2 hours ago

Pentixapharm Prepares for Phase 3 PANDA Study on Hypertension Diagnostic

FDA Feedback Hypertension Phase 3 Study Radiodiagnostic CXCR4 Targeting
PRESS RELEASE

published on 12/03/2025 at 08:00, 2 days 2 hours ago

Pentixapharm Advances Regulatory Preparations for Phase 3 PANDA Study with Radiodiagnostic Candidate 68Ga-PentixaFor in Hypertension
Pentixapharm advances regulatory preparations for Phase 3 PANDA study with radiodiagnostic candidate 68Ga-PentixaFor in hypertension. FDA provides feedback on clinical protocol

FDA Feedback Hypertension Pentixapharm Phase 3 PANDA Study 68Ga-PentixaFor
BRIEF

published on 11/12/2025 at 08:05, 23 days 2 hours ago

Pentixapharm publie ses résultats financiers pour les 9 premiers mois de 2025

Perte Financière Revenu Pentixapharm Résultats À 9 Mois Ajustement Des Directives
BRIEF

published on 11/12/2025 at 08:05, 23 days 2 hours ago

Pentixapharm Reports 9-Month Financial Results for 2025

Revenue Financial Loss Guidance Adjustment Pentixapharm 9-Month Results
PRESS RELEASE

published on 11/12/2025 at 08:00, 23 days 2 hours ago

Pentixapharm Publishes 9-Month Figures for 2025
Pentixapharm announces 9-month figures for 2025, reports €12.7 million loss. Adjusted guidance projects approximately €18 million loss for the fiscal year. New financial statements available on website

Financial Statements 2025 Loss 9-month Figures Pentixapharm
BRIEF

published on 11/10/2025 at 08:05, 25 days 2 hours ago

Pentixapharm publiera ses résultats financiers pour le troisième trimestre et les neuf premiers mois de 2025.

Résultats Financiers Biotechnologie Oncologie Produits Radiopharmaceutiques Pentixapharm
BRIEF

published on 11/10/2025 at 08:05, 25 days 2 hours ago

Pentixapharm to Release Financial Results for Q3 and Nine Months of 2025

Financial Results Oncology Biotech Radiopharmaceuticals Pentixapharm
PRESS RELEASE

published on 11/10/2025 at 08:00, 25 days 2 hours ago

Pentixapharm to Report Third Quarter and First Nine Months 2025 Financial Results on Wednesday, November 12, 2025
Pentixapharm Holding AG to release Third Quarter and First Nine Months 2025 Financial Results on November 12, 2025. Conference call and webcast to follow

Financial Results Conference Call Berlin Radiopharmaceuticals Pentixapharm
BRIEF

published on 11/06/2025 at 20:00, 28 days 14 hours ago

Pentixapharm Holding AG Reduces Projected Loss for 2025

Biotech Industry Clinical Development Cost Reduction Financial Forecast Strategic Optimization

1 2 ... 9

Accesswire

Published on 12/05/2025 at 02:35, 8 hours ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 8 hours 5 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 9 hours 35 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 11 hours 30 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 11 hours 35 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 10:15, 20 minutes ago

Wuxi’s Liangxi District: Where 3,000 Years of Jiangnan Culture Thrives
Published on 12/05/2025 at 09:40, 55 minutes ago

Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 09:30, 1 hour 5 minutes ago

REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany
Published on 12/05/2025 at 09:05, 1 hour 30 minutes ago

Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 09:00, 1 hour 35 minutes ago

Original-Research: DEMIRE AG (von NuWays AG): BUY

Les Echos

Published on 12/05/2025 at 08:45, 1 hour 50 minutes ago

Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 1 hour 50 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 1 hour 53 minutes ago

ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 16 hours 21 minutes ago

Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 16 hours 35 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025

View all LES ECHOS COMFI WIRE